World Journal of Surgery

, Volume 42, Issue 8, pp 2476–2484 | Cite as

Percutaneous Laser Ablation of Unifocal Papillary Thyroid Microcarcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Assessing Local Therapeutic Response

  • Lu Zhang
  • Wei ZhouEmail author
  • Weiwei Zhan
  • Yan Peng
  • Shan Jiang
  • Shangyan Xu
Original Scientific Report



To investigate the use of conventional ultrasound and contrast-enhanced ultrasound (CEUS) in assessing local therapeutic response of percutaneous laser ablation (PLA) for papillary thyroid microcarcinoma (PTMC).


Sixty-four patients with 64 PTMCs who were referred to our hospital from November 2013 to July 2016 were treated with PLA. The extent of ablation was assessed by CEUS at 10–20 min and 7 days after PLA. The size and volume of the ablation zone were evaluated on conventional ultrasound at 1 h, 1, 3, 6 and 12 months, and every half-year thereafter, and recurrences were also recorded. Ultrasound-guided fine needle aspiration biopsy (FNAB) of the ablated area was performed at 1, 6 and 12 months after PLA.


Two incomplete ablations were detected by CEUS, and a second ablation was performed. The mean largest diameter and volume of the ablated area on CEUS at 10–20 min and 7 days after PLA were significantly larger than those of pre-treatment on conventional ultrasound (p < 0.05, for both). At the last follow-up, the mean largest diameter was reduced from 4.6 ± 1.5 to 0.6 ± 1.3 mm (p < 0.0.5), and the average volume was 41.0 ± 40.4 mm3, which decreased to 1.8 ± 6.7 mm3 (p < 0.0.5). A cervical metastatic lymph node was detected on ultrasound and confirmed by ultrasound-guided FNAB at 30 months after PLA.


CEUS could play a crucial role in assessing the completeness of PLA for treating PTMC, and conventional ultrasound can not only guide the FNAB process but also is important in the follow-up of PTMC after PLA.



Papillary thyroid microcarcinoma


Contrast-enhanced ultrasound




Percutaneous laser ablation


Fine needle aspiration biopsy



This work was supported by Grants from the Capacity building project of auxiliary department (Ultrasonic Medicine), clinical science and technology innovation project from Shanghai Shen Kang Hospital Development Center (No. SHDC22015006), Science and technology commission foundation of Shanghai (No. 14411961000).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Kilfoy BA, Zheng T, Holford TR et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20:525–531CrossRefPubMedGoogle Scholar
  2. 2.
    Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167CrossRefPubMedGoogle Scholar
  3. 3.
    Ito Y, Miyauchi A, Inoue H et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28–35. CrossRefPubMedGoogle Scholar
  4. 4.
    Papini E, Guglielmi R, Gharib H et al (2011) Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid 21:917–920CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Yue W, Wang S, Yu S et al (2014) Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperth 30:150–157CrossRefGoogle Scholar
  6. 6.
    Zhang M, Luo Y, Zhang Y et al (2016) Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid 26:1581–1587CrossRefPubMedGoogle Scholar
  7. 7.
    Zhou W, Jiang S, Zhan W et al (2017) Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: preliminary results. Eur Radiol 27:2934–2940CrossRefPubMedGoogle Scholar
  8. 8.
    Ricci P, Cantisani V, Drudi F et al (2009) Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma? Ultraschall Med 30:252–258CrossRefPubMedGoogle Scholar
  9. 9.
    Nishigaki Y, Hayashi H, Tomita E et al (2015) Usefulness of contrast-enhanced ultrasonography using Sonazoid for the assessment of therapeutic response to percutaneous radiofrequency ablation for hepatocellular carcinoma. Hepatol Res 45:432–440CrossRefPubMedGoogle Scholar
  10. 10.
    Zhang B, Jiang YX, Liu JB et al (2010) Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules. Thyroid 20:51–57CrossRefPubMedGoogle Scholar
  11. 11.
    Yue W, Wang S, Wang B et al (2013) Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur J Radiol 82:e11–e16CrossRefPubMedGoogle Scholar
  12. 12.
    Guang Y, Luo Y, Zhang Y et al (2017) Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma. J Cancer Res Clin Oncol 143:1555–1562CrossRefPubMedGoogle Scholar
  13. 13.
    Li X, Liang P, Yu J et al (2013) Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma. Radiol Oncol 47:398–404CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Du J, Li HL, Zhai B et al (2015) Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results. Ultrasound Med Biol 41:2400–2411CrossRefPubMedGoogle Scholar
  15. 15.
    Choi D, Lim HK, Lee WJ et al (2003) Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 22:1163–1172CrossRefPubMedGoogle Scholar
  16. 16.
    Spiezia S, Vitale G, Di Somma C et al (2003) Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid 13:941–947CrossRefPubMedGoogle Scholar
  17. 17.
    Zhou W, Zhang L, Zhan W et al (2016) Percutaneous laser ablation for treatment of locally recurrent papillary thyroid carcinoma <15 mm. Clin Radiol 71:1233–1239CrossRefPubMedGoogle Scholar
  18. 18.
    McGhana JP, Dodd GD 3rd (2001) Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 176:3–16CrossRefPubMedGoogle Scholar
  19. 19.
    Lim HK, Choi D, Lee WJ et al (2001) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221:447–454CrossRefPubMedGoogle Scholar
  20. 20.
    Wang TS, Goffredo P, Sosa JA et al (2014) Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg 38:2297–2303. CrossRefPubMedGoogle Scholar
  21. 21.
    Pellegriti G, Scollo C, Lumera G et al (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713–3720CrossRefPubMedGoogle Scholar
  22. 22.
    Valcavi R, Piana S, Bortolan GS et al (2013) Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid 23:1578–1582CrossRefPubMedGoogle Scholar
  23. 23.
    Goldberg SN (2001) Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 13:129–147CrossRefPubMedGoogle Scholar
  24. 24.
    Meloni MF, Andreano A, Franza E et al (2012) Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur J Radiol 81:e897–e902CrossRefPubMedGoogle Scholar
  25. 25.
    Wu H, Wilkins LR, Ziats NP et al (2014) Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver model. Radiology 270:107–116CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Wu JY, Chen MH, Yang W et al (2012) Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma. Chin J Cancer Res 24:44–51CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Meloni MF, Smolock A, Cantisani V et al (2015) Contrast enhanced ultrasound in the evaluation and percutaneous treatment of hepatic and renal tumors. Eur J Radiol 84:1666–1674CrossRefPubMedGoogle Scholar
  28. 28.
    Zhou L, Keane D, Reed G et al (1999) Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions. J Cardiovasc Electrophysiol 10:611–620CrossRefPubMedGoogle Scholar
  29. 29.
    Sumagin R, Prizant H, Lomakina E et al (2010) LFA-1 and Mac-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ. J Immunol 185:7057–7066CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Zhang L, Zhou W, Zhan W (2017) Role of ultrasound in the assessment of percutaneous laser ablation of cervical metastatic lymph nodes from thyroid carcinoma. Acta Radiol.
  31. 31.
    Shin LK, Olcott EW, Jeffrey RB et al (2013) Sonographic evaluation of cervical lymph nodes in papillary thyroid cancer. Ultrasound Q 29:25–32CrossRefPubMedGoogle Scholar
  32. 32.
    Hay ID, Charboneau JW (2011) The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 96:2717–2720CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2018

Authors and Affiliations

  • Lu Zhang
    • 1
  • Wei Zhou
    • 1
    • 2
    Email author
  • Weiwei Zhan
    • 1
  • Yan Peng
    • 1
  • Shan Jiang
    • 1
  • Shangyan Xu
    • 1
  1. 1.Department of Ultrasound, Rui Jin Hospital, School of MedicineShanghai Jiao Tong UniversityShanghaiChina
  2. 2.Department of Ultrasound, Luwan Branch, Rui Jin Hospital, School of MedicineShanghai Jiao Tong UniversityShanghaiChina

Personalised recommendations